Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Amy Ritter was Scientific Editor, BioPharm International.

Articles

Mylan announced that it has signed an agreement to acquire the generic injectables unit Agila Specialties from Strides Arcolab for $1.6 billion in cash.

Mylan Acquires Generic Injectables Unit From Strides Arcolab

Simon Chalk is director of the BioPhorum Operations Group, simon@biophorum.com.

Companies risk drowning in alphabet soup if the latest three-letter acronym improvement strategy isn't clearly linked to business strategy.

Relevance Regained

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Applying quality-by-design and process analytical technology facilitates process understanding and control of various operations in lyophilization.

Advances in PAT for Parenteral Drug Manufacturing

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

Vaccine development is benefiting from manufacturing advances and support for global health.

Vaccine Innovation Yields New Products and Processes

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Growth is seen in outsourcing of insect- and plant-cell-based bioproduction expression systems.

Outsourcing Nontraditional Protein Expression Systems

Recent advances in equipment design and operation in spraying, drying, and mixing can improve the tablet-coating process.

Continuous Improvement in Tablet Coating and Dry Granulation

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

The tableting science anti-research (TSAR) project seeks to understand why certain formulations stick to tablet tooling.

Tackling Common Problems in Tableting and Tooling

A roundtable discussion of the challenges and innovations in tablet splitting featuring Freeman Technology, Accu-Break Pharmaceuticals, and Medelpharm.

Concerns and Innovations in Tablet Splitting and Scoring

An alternative chapter has been added to the European Pharmacopoeia for dosage uniformity.

The Ph.Eur. approach to tablet splitting

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Custom manufacturers with expertise in highly potent API production discuss the latest issues and technology developments in the field.